In this application for a Core Support Center, we propose to apply the technologies of functional genomics to the study of hepatitis C virus (HCV)-associated liver disease, a public health problem that is a direct consequence of drug abuse and addiction. This center will be composed of a diverse group of NIH-funded investigators, including experts in viral hepatitis, liver disease and transplantation, global gene expression analysis, proteomics, and advanced information technologies. The unifying theme is the desire to gain a detailed understanding of the molecular mechanisms underlying the progression from chronic HCV infection to end-stage liver disease, including cirrhosis and hepatocellular carcinoma. The University of Washington provides an exceptional environment that has fostered a high level of expertise in all these venues, and it is only through a Core Support Center that such a multidisciplinary group of researchers can be brought together to focus their expertise on a single problem. The proposed center will consist of four cores: Microarray & Virology, Proteomics & Modeling, Bioinformatics & Biostatistics, and Administration. Investigators from basic and clinical science will participate in the Microarray & Virology Core, providing a primary human hepatocyte cell culture system and access to unique patient populations, including biopsy material from patients with recurrent HCV after liver transplantation, and from patients co-infected with HCV and human immunodeficiency virus. An established infrastructure is in place for microarray analysis, including extensive experience in gene expression analysis during virus infection. The Proteomics & Modeling core will be located at the Institute for Systems Biology, one of the world's leading proteomics centers. Specialists in computational biology, bioinformatics, and statistics will provide the essential functions of data management, analysis, and statistical evaluation. This group will also develop a national database resource of gene expression and proteomics data that can be accessed via the World Wide Web. This multidisciplinary approach provides a unique opportunity to advance our understanding of viral hepatitis and liver disease to a level far in excess of that which could be obtained by any of these investigators working individually. The Core Support Center provides the mechanism to bring this outstanding group of scientists together and to attract additional scientists of the highest quality.

Agency
National Institute of Health (NIH)
Institute
National Institute on Drug Abuse (NIDA)
Type
Center Core Grants (P30)
Project #
5P30DA015625-03
Application #
6776892
Study Section
Special Emphasis Panel (ZDA1-RXL-E (01))
Program Officer
Pollock, Jonathan D
Project Start
2002-09-30
Project End
2007-05-31
Budget Start
2004-06-01
Budget End
2005-05-31
Support Year
3
Fiscal Year
2004
Total Cost
$1,738,330
Indirect Cost
Name
University of Washington
Department
Microbiology/Immun/Virology
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
Britton, Laura-Mae P; Sova, Pavel; Belisle, Sarah et al. (2014) A proteomic glimpse into the initial global epigenetic changes during HIV infection. Proteomics 14:2226-30
Palermo, Robert E; Tisoncik-Go, Jennifer; Korth, Marcus J et al. (2013) Old world monkeys and new age science: the evolution of nonhuman primate systems virology. ILAR J 54:166-80
Chang, Stewart T; Thomas, Matthew J; Sova, Pavel et al. (2013) Next-generation sequencing of small RNAs from HIV-infected cells identifies phased microrna expression patterns and candidate novel microRNAs differentially expressed upon infection. MBio 4:e00549-12
Korth, Marcus J; Tchitchek, Nicolas; Benecke, Arndt G et al. (2013) Systems approaches to influenza-virus host interactions and the pathogenesis of highly virulent and pandemic viruses. Semin Immunol 25:228-39
Selinger, Christian; Katze, Michael G (2013) Mathematical models of viral latency. Curr Opin Virol 3:402-7
Law, G Lynn; Tisoncik-Go, Jennifer; Korth, Marcus J et al. (2013) Drug repurposing: a better approach for infectious disease drug discovery? Curr Opin Immunol 25:588-92
Law, G Lynn; Korth, Marcus J; Benecke, Arndt G et al. (2013) Systems virology: host-directed approaches to viral pathogenesis and drug targeting. Nat Rev Microbiol 11:455-66
McDermott, Jason E; Diamond, Deborah L; Corley, Courtney et al. (2012) Topological analysis of protein co-abundance networks identifies novel host targets important for HCV infection and pathogenesis. BMC Syst Biol 6:28
Diamond, Deborah L; Krasnoselsky, Alexei L; Burnum, Kristin E et al. (2012) Proteome and computational analyses reveal new insights into the mechanisms of hepatitis C virus-mediated liver disease posttransplantation. Hepatology 56:28-38
Navare, Arti T; Sova, Pavel; Purdy, David E et al. (2012) Quantitative proteomic analysis of HIV-1 infected CD4+ T cells reveals an early host response in important biological pathways: protein synthesis, cell proliferation, and T-cell activation. Virology 429:37-46

Showing the most recent 10 out of 49 publications